RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Clinical trials for RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM) trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental 'Off-the-Shelf' cell therapy targets tough blood cancer
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy for adults with multiple myeloma that has returned or stopped responding to standard treatments. The therapy uses immune cells (CAR-T cells) from donated umbilical cord blood, modified to attack two targets on cancer ce…
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New cell therapy trial offers hope for Tough-to-Treat blood cancer
Disease control Recruiting nowThis study is testing an experimental cell therapy called LCAR-F33S for people with multiple myeloma that has returned or stopped responding to standard treatments. Researchers will give the therapy to about 35 patients to check how safe it is and whether it can help control the …
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Phase: NA • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Mar 23, 2026 15:19 UTC
-
New immune cell therapy tested for Tough-to-Treat blood cancer
Disease control Recruiting nowThis early-stage study is testing a new type of CAR-T cell therapy called HBI0101 in adults with multiple myeloma that has come back or stopped responding to standard treatments. The main goals are to find a safe dose and check for side effects. Researchers will also look for ear…
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA (MM)
Phase: PHASE1 • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC